79070126 - BIONORICA

Information

  • Trademark
  • 79070126
  • Serial Number
    79070126
  • Registration Number
    3870253
  • Filing Date
    March 26, 2009
    15 years ago
  • Registration Date
    November 02, 2010
    14 years ago
  • Transaction Date
    August 02, 2024
    5 months ago
  • Status Date
    December 15, 2020
    4 years ago
  • Published for Opposition Date
    August 17, 2010
    14 years ago
  • Location Date
    December 15, 2020
    4 years ago
  • Status Code
    706
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    LOTT, MAUREEN DALL
  • Attorney Docket Number
    2194-TM-002
    Attorney Name
    KENNETH F. FLOREK
    Law Office Assigned Location Code
    M80
  • Owners
Mark Drawing Code
4
Mark Identification
BIONORICA
Case File Statements
  • GS0051: Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of [ gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, ] angina, [ atherosclerosis, ] bronchial asthma, [ circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climacteric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, nephrolithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, ] inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, [ arthritis, osteoarthritis, ] fever, cough, cold, [ Alzheimer's disease, ] infection of respiratory tract, [ infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, analeptic, and tranquilizer; haemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; medicinal preparations in tablet form, namely, menstruation circulation regulating tablets; pharmaceutical preparations, namely, for hormone regulation and hormone replacement; ] pharmaceutical preparations for sensory organs, namely, for use in [ ophthalmology, ] otolaryngology [ and dermatology] ; pharmaceutical preparations for regulation and strengthening of the immune system, [ pharmaceutical preparations for treating of and providing temporary relief for occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of medicated balms, medicated dental tapes, medicated dental ribbons, medicated dental polish; pharmaceutical preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria and caries, diagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; medicated mouth sprays, ] plant extracts for [ veterinary and ] pharmaceutical purposes; [ sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for health purposes; medicated sanitary preparations for the treatment, cleaning and protection of the skin; ] dietary supplements in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form, containing plant extracts; dietetic foods adapted for medical use in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form; [ food for medically restricted diets, food for diabetics, ] food supplements containing plant extracts, food supplements derived from plants or plant extracts, all aforesaid goods in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form; [ vitamin and mineral supplements; food and food supplements, namely, herbal teas for medicinal purposes and medicinal teas; nutritional additives for use in foods and dietary supplements for human consumption; ] dietetic food supplements, dietary supplements, food supplements and dietary food supplements; [ mineral food supplements, food supplements based on amino acids, minerals and/or trace elements, medical plasters; materials for dressings, namely, gauze and bandages; all purpose disinfectants, material for stopping teeth; dental wax ]
  • GS0161: [ Paper; cardboard; goods made from paper and cardboard, namely, paper bags, coasters, and works of art in the nature of art prints; printed matter, namely, books, magazines, journals, newspapers, periodicals, leaflets, manuals, catalogs and brochures in the fields of health and medicine; printed reviews in the nature of a series of written articles in the fields of health and medicine; bookbinding material, namely, book bindings; photographs; stationery; adhesives for stationery or household purposes; artists' materials, namely, artists' pastels, artists' pencils, artists' pens, painting sets for children; paint brushes; typewriters; office requisites except furniture, namely, punches, staplers, erasers, desk pads, pencil sharpeners; instructional and teaching material, namely, printed instructional and teaching material in the field of medicine and phytopharmacy; paper bags, envelopes and pouches for packaging, plastic bags and bubble packs for packaging ]
  • GS0031: [ Essential oils for use in the manufacture of cosmetics, hair lotions and perfumery; hair lotions; dentifrices ]
Case File Event Statements
  • 8/3/2009 - 15 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/23/2009 - 15 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 7/23/2009 - 15 years ago
    2 - LIMITATION OF GOODS/SERVICES FROM IB ENTERED Type: LIMS
  • 7/24/2009 - 15 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/24/2009 - 15 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/28/2009 - 15 years ago
    5 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/31/2009 - 15 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/1/2009 - 15 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 8/3/2009 - 15 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/24/2010 - 14 years ago
    18 - FAX RECEIVED Type: FAXX
  • 10/3/2009 - 15 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/25/2010 - 14 years ago
    11 - PAPER RECEIVED Type: MAIL
  • 2/23/2010 - 14 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 2/26/2010 - 14 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/26/2010 - 14 years ago
    14 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 2/26/2010 - 14 years ago
    15 - REPORT UNRESPONSIVE AMENDMENT - COMPLETED Type: NAUD
  • 2/26/2010 - 14 years ago
    16 - NOTICE OF UNRESPONSIVE AMENDMENT - MAILED Type: NAUD
  • 3/23/2010 - 14 years ago
    17 - FAX RECEIVED Type: FAXX
  • 3/24/2010 - 14 years ago
    21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/26/2010 - 14 years ago
    22 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 5/29/2010 - 14 years ago
    29 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/26/2010 - 14 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/26/2010 - 14 years ago
    20 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 4/13/2010 - 14 years ago
    23 - REPORT UNRESPONSIVE AMENDMENT - COMPLETED Type: NAUD
  • 4/14/2010 - 14 years ago
    24 - NOTICE OF UNRESPONSIVE AMENDMENT - MAILED Type: NAUD
  • 5/12/2010 - 14 years ago
    26 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/12/2010 - 14 years ago
    25 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/28/2010 - 14 years ago
    27 - ASSIGNED TO LIE Type: ALIE
  • 5/29/2010 - 14 years ago
    28 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/7/2010 - 14 years ago
    33 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/7/2010 - 14 years ago
    30 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/7/2010 - 14 years ago
    31 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/7/2010 - 14 years ago
    32 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/9/2010 - 14 years ago
    39 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/14/2010 - 14 years ago
    34 - PRIORITY ACTION WRITTEN Type: CPRA
  • 6/14/2010 - 14 years ago
    35 - PRIORITY ACTION E-MAILED Type: GPRA
  • 6/14/2010 - 14 years ago
    36 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 7/9/2010 - 14 years ago
    37 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/9/2010 - 14 years ago
    38 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/9/2010 - 14 years ago
    40 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/2/2011 - 13 years ago
    48 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 2/11/2011 - 13 years ago
    49 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 7/9/2010 - 14 years ago
    41 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/12/2010 - 14 years ago
    42 - ASSIGNED TO LIE Type: ALIE
  • 7/12/2010 - 14 years ago
    43 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 8/17/2010 - 14 years ago
    44 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/17/2010 - 14 years ago
    45 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/2/2010 - 14 years ago
    46 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD
  • 11/2/2010 - 14 years ago
    47 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/7/2017 - 7 years ago
    59 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INPS
  • 2/11/2011 - 13 years ago
    50 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 2/18/2013 - 11 years ago
    51 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 6/12/2014 - 10 years ago
    52 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 10/12/2016 - 8 years ago
    53 - TEAS SECTION 71 RECEIVED Type: ES71
  • 3/28/2017 - 7 years ago
    54 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 3/29/2017 - 7 years ago
    55 - REGISTERED - PARTIAL SEC 71 ACCEPTED Type: 71.P
  • 3/29/2017 - 7 years ago
    56 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71
  • 11/29/2017 - 7 years ago
    57 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 12/7/2017 - 7 years ago
    58 - INVALIDATION PROCESSED Type: INPC
  • 1/11/2018 - 7 years ago
    60 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP
  • 4/11/2019 - 5 years ago
    61 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL
  • 11/2/2019 - 5 years ago
    62 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4
  • 9/16/2020 - 4 years ago
    63 - TEAS SECTION 71 RECEIVED Type: ES71
  • 8/15/2021 - 3 years ago
    67 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 12/9/2020 - 4 years ago
    64 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 12/15/2020 - 4 years ago
    65 - REGISTERED-SEC.71 ACCEPTED Type: 71AG
  • 12/15/2020 - 4 years ago
    66 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71
  • 2/17/2023 - a year ago
    69 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 9/1/2021 - 3 years ago
    68 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA
  • 4/22/2023 - a year ago
    70 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 9/9/2023 - a year ago
    71 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/18/2024 - 7 months ago
    73 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 8/1/2024 - 5 months ago
    74 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/3/2024 - 8 months ago
    72 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP